Atlas Trials

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies

Clinical trial NCT05315583 · TERMINATED

Trial details

NCT number
NCT05315583
Sponsor
Centre Hospitalier Régional d'Orléans
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19SARS CoV 2 Infection
Start date
2022-12-01
Primary completion
2023-03-16
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.